Israel Englander Sangamo Therapeutics, Inc Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Millennium Management LLC holds 229,400 shares of SGMO stock, worth $119,288. This represents 0.0% of its overall portfolio holdings.
Number of Shares
229,400
Previous 329,400
30.36%
Holding current value
$119,288
Previous $335,000
54.93%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding SGMO
# of Institutions
140Shares Held
55.7MCall Options Held
2.22MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.87 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.57 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$3.56 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.45 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$1.21 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $81.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...